001     128312
005     20240228145539.0
024 7 _ |a 10.1016/j.ccell.2017.08.010
|2 doi
024 7 _ |a pmid:28898696
|2 pmid
024 7 _ |a pmc:PMC5598544
|2 pmc
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:25114001
|2 altmetric
037 _ _ |a DKFZ-2017-04329
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Boege, Yannick
|b 0
245 _ _ |a A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.
260 _ _ |a Cambridge, Mass.
|c 2017
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1533801931_8713
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Concomitant hepatocyte apoptosis and regeneration is a hallmark of chronic liver diseases (CLDs) predisposing to hepatocellular carcinoma (HCC). Here, we mechanistically link caspase-8-dependent apoptosis to HCC development via proliferation- and replication-associated DNA damage. Proliferation-associated replication stress, DNA damage, and genetic instability are detectable in CLDs before any neoplastic changes occur. Accumulated levels of hepatocyte apoptosis determine and predict subsequent hepatocarcinogenesis. Proliferation-associated DNA damage is sensed by a complex comprising caspase-8, FADD, c-FLIP, and a kinase-dependent function of RIPK1. This platform requires a non-apoptotic function of caspase-8, but no caspase-3 or caspase-8 cleavage. It may represent a DNA damage-sensing mechanism in hepatocytes that can act via JNK and subsequent phosphorylation of the histone variant H2AX.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Fadd protein, mouse
|2 NLM Chemicals
650 _ 7 |a Fas-Associated Death Domain Protein
|2 NLM Chemicals
650 _ 7 |a Histones
|2 NLM Chemicals
650 _ 7 |a Mcl1 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Myeloid Cell Leukemia Sequence 1 Protein
|2 NLM Chemicals
650 _ 7 |a Receptors, Tumor Necrosis Factor, Type I
|2 NLM Chemicals
650 _ 7 |a gamma-H2AX protein, mouse
|2 NLM Chemicals
650 _ 7 |a Receptor-Interacting Protein Serine-Threonine Kinases
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a Ripk1 protein, mouse
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a JNK Mitogen-Activated Protein Kinases
|0 EC 2.7.11.24
|2 NLM Chemicals
650 _ 7 |a Caspase 8
|0 EC 3.4.22.-
|2 NLM Chemicals
700 1 _ |a Malehmir, Mohsen
|b 1
700 1 _ |a Healy, Marc E
|b 2
700 1 _ |a Bettermann, Kira
|b 3
700 1 _ |a Lorentzen, Anna
|b 4
700 1 _ |a Vucur, Mihael
|b 5
700 1 _ |a Ahuja, Akshay K
|b 6
700 1 _ |a Böhm, Friederike
|b 7
700 1 _ |a Mertens, Joachim C
|b 8
700 1 _ |a Shimizu, Yutaka
|b 9
700 1 _ |a Frick, Lukas
|b 10
700 1 _ |a Remouchamps, Caroline
|b 11
700 1 _ |a Mutreja, Karun
|b 12
700 1 _ |a Kähne, Thilo
|b 13
700 1 _ |a Sundaravinayagam, Devakumar
|b 14
700 1 _ |a Wolf, Monika J
|b 15
700 1 _ |a Rehrauer, Hubert
|b 16
700 1 _ |a Koppe, Christiane
|b 17
700 1 _ |a Speicher, Tobias
|b 18
700 1 _ |a Padrissa-Altés, Susagna
|b 19
700 1 _ |a Maire, Renaud
|b 20
700 1 _ |a Schattenberg, Jörn M
|b 21
700 1 _ |a Jeong, Ju-Seong
|b 22
700 1 _ |a Liu, Lei
|b 23
700 1 _ |a Zwirner, Stefan
|0 P:(DE-HGF)0
|b 24
700 1 _ |a Boger, Regina
|b 25
700 1 _ |a Hüser, Norbert
|b 26
700 1 _ |a Davis, Roger J
|b 27
700 1 _ |a Müllhaupt, Beat
|b 28
700 1 _ |a Moch, Holger
|b 29
700 1 _ |a Schulze-Bergkamen, Henning
|b 30
700 1 _ |a Clavien, Pierre-Alain
|b 31
700 1 _ |a Werner, Sabine
|b 32
700 1 _ |a Borsig, Lubor
|b 33
700 1 _ |a Luther, Sanjiv A
|b 34
700 1 _ |a Jost, Philipp J
|b 35
700 1 _ |a Weinlich, Ricardo
|b 36
700 1 _ |a Unger, Kristian
|b 37
700 1 _ |a Behrens, Axel
|b 38
700 1 _ |a Hillert, Laura
|b 39
700 1 _ |a Dillon, Christopher
|b 40
700 1 _ |a Di Virgilio, Michela
|b 41
700 1 _ |a Wallach, David
|b 42
700 1 _ |a Dejardin, Emmanuel
|b 43
700 1 _ |a Zender, Lars
|0 P:(DE-He78)1ba2900406378e069d32db376c7818db
|b 44
|u dkfz
700 1 _ |a Naumann, Michael
|b 45
700 1 _ |a Walczak, Henning
|b 46
700 1 _ |a Green, Douglas R
|b 47
700 1 _ |a Lopes, Massimo
|b 48
700 1 _ |a Lavrik, Inna
|b 49
700 1 _ |a Luedde, Tom
|b 50
700 1 _ |a Heikenwalder, Mathias
|0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
|b 51
|u dkfz
700 1 _ |a Weber, Achim
|b 52
773 _ _ |a 10.1016/j.ccell.2017.08.010
|g Vol. 32, no. 3, p. 342 - 359.e10
|0 PERI:(DE-600)2074034-7
|n 3
|p 342 - 359.e10
|t Cancer cell
|v 32
|y 2017
|x 1535-6108
909 C O |p VDB
|o oai:inrepo02.dkfz.de:128312
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 44
|6 P:(DE-He78)1ba2900406378e069d32db376c7818db
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)V076-20160331
|k V076
|l Translationale Gastrointestinale Onkologie
|x 0
920 1 _ |0 I:(DE-He78)F180-20160331
|k F180
|l Chronische Entzündung und Krebs
|x 1
920 1 _ |0 I:(DE-He78)L801-20160331
|k L801
|l DKTK Tübingen
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)V076-20160331
980 _ _ |a I:(DE-He78)F180-20160331
980 _ _ |a I:(DE-He78)L801-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21